RecruitingPHASE1, PHASE2NCT06138743

Study of ARO-DM1 in Subjects With Type 1 Myotonic Dystrophy

Studying Myotonic dystrophy

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Arrowhead Pharmaceuticals
Intervention
ARO-DM1 Intravenous (IV) Infusion(drug)
Enrollment
78 enrolled
Eligibility
18-65 years · All sexes
Timeline
20242026

Study locations (10)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06138743 on ClinicalTrials.gov

Other trials for Myotonic dystrophy

Additional recruiting or active studies for the same condition.

See all trials for Myotonic dystrophy

← Back to all trials